Health Catalyst (HCAT) Reports Q2: Everything You Need To Know Ahead Of EarningsHealthcare software provider Health Catalyst (
NASDAQ:HCAT)
will be reporting results this Thursday after market hours. Here’s what you need to know.
Unity, Domo, Five9, Health Catalyst, and Shopify Shares Skyrocket, What You Need To KnowA number of stocks jumped in the afternoon session after the Software as a Service (SaaS) sector rebounded following the sell-off in the previous trading session as a weaker-than-expected U.S. jobs report increased the probability of a Federal Reserve interest rate cut. The July Nonfarm Payrolls (NFP) report showed the U.S. economy added only 73,000 jobs, significantly below the 110,000 forecast. This, combined with downward revisions for May and June, signaled a cooling labor market to investors. In response, market expectations for a September interest rate cut by the Federal Reserve surged from roughly 40% to over 80%. A potential rate cut is generally favorable for growth sectors like technology and SaaS, as lower rates can increase the present value of their future earnings, boosting stock valuations.
1 Value Stock with Solid Fundamentals and 2 Facing HeadwindsValue stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Why Health Catalyst (HCAT) Stock Is Up TodayShares of healthcare software provider Health Catalyst (
NASDAQ:HCAT)
jumped 6.6% in the afternoon session after the stock gained ground amid broader positive market sentiment ahead of a busy week for corporate earnings.
3 Unprofitable Stocks We Approach with CautionUnprofitable companies face headwinds as they struggle to keep operating expenses under control.
Some may be investing heavily, but the majority fail to convert spending into sustainable growth.
Health Catalyst to Announce Second Quarter 2025 Operating Results and Host Conference Call on Thursday, August 7, 2025SALT LAKE CITY, July 17, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its second quarter 2025 operating results on Thursday, August 7, 2025, after market close. In conjunction, the company will host a conference call to review the results at 5:00 pm ET on the same day.
3 Cash-Burning Stocks with Open QuestionsWhile some companies burn cash to fuel expansion, others struggle to turn spending into sustainable growth.
A high cash burn rate without a strong balance sheet can leave investors exposed to significant downside.
3 Russell 2000 Stocks in Hot WaterThe Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on.
However, these companies often come with higher volatility and risk, as their smaller size makes them more vulnerable to economic downturns.
Data Analytics Stocks Q1 Teardown: Health Catalyst (NASDAQ:HCAT) Vs The RestAs the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (
NASDAQ:HCAT) and its peers.
HCAT Q1 Earnings Call: Ignite Platform Drives Client Growth Amid Funding UncertaintyHealthcare software provider Health Catalyst (
NASDAQ:HCAT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.3% year on year to $79.41 million. On the other hand, next quarter’s revenue guidance of $80.5 million was less impressive, coming in 3.1% below analysts’ estimates. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
Health Catalyst, Steven Madden, Astronics, Wayfair, and Robinhood Shares Are Soaring, What You Need To KnowA number of stocks jumped in the pre-market session after the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025.
1 of Wall Street’s Favorite Stock for Long-Term Investors and 2 to QuestionWall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential.
However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.
Health Catalyst to Participate in Upcoming Investor ConferencesSALT LAKE CITY, May 20, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Jason Alger, Chief Financial Officer, and Jack Knight, Vice President of Investor Relations, will participate in the following upcoming investor conferences:
3 Stocks Under $10 with Questionable FundamentalsInvestors can certainly boost their returns by concentrating on stocks trading between $1 and $10.
However, a disciplined approach is necessary because many of these businesses are speculative and lack the underlying fundamentals to support their prices.
1 Mooning Stock Worth Your Attention and 2 to AvoidGreat things are happening to the stocks in this article.
They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.
Health Catalyst (NASDAQ:HCAT) Posts Q1 Sales In Line With Estimates, Stock SoarsHealthcare software provider Health Catalyst (
NASDAQ:HCAT) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 6.3% year on year to $79.41 million. On the other hand, next quarter’s revenue guidance of $80.5 million was less impressive, coming in 3.1% below analysts’ estimates. Its non-GAAP profit of $0.01 per share was in line with analysts’ consensus estimates.
Health Catalyst Reports First Quarter 2025 ResultsSALT LAKE CITY, May 07, 2025 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2025.
Health Catalyst (HCAT) Reports Earnings Tomorrow: What To ExpectHealthcare software provider Health Catalyst (
NASDAQ:HCAT)
will be reporting earnings tomorrow after the bell. Here’s what you need to know.
Q4 Earnings Outperformers: Health Catalyst (NASDAQ:HCAT) And The Rest Of The Data Analytics StocksAs the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the data analytics industry, including Health Catalyst (
NASDAQ:HCAT) and its peers.
Cadence, DocuSign, Health Catalyst, UiPath, and Amplitude Shares Are Soaring, What You Need To KnowA number of stocks jumped in the afternoon session after stocks extended their rebound, led by strong gains in the technology sector, as renewed optimism surrounding U.S.–China trade negotiations lifted investor sentiment.